GW Pharma to Raise up to $258.75 Million in Underwritten Deal

GW Pharmaceuticals Announces Proposed Public Offering of ADSs LONDON, Dec. 05, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPRF) (Nasdaq:GWPH) (“GW” or the “Company”), a biopharmaceutical company focused on...
- December 5th, 2017 at 4:38 pm

Canopy Growth Details Danish Cannabis Production Facility

Spectrum Cannabis Denmark Announces Forty Thousand Square Metre Medical Cannabis Facility in Odense Hi-tech Greenhouse Positions Spectrum Cannabis as European Cannabis Leader & Odense as Major European Medical Cannabis...
- December 5th, 2017 at 7:18 am

GW Pharma Expects FDA Decision on Epidiolex in Mid-2018

GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress Epidiolex® (cannabidiol) NDA Submitted to FDA Conference call today at 7:30 a.m. EST LONDON...
- December 4th, 2017 at 7:42 am

Cann Group Raised AUS$58.7 Million

  Cann Group ( ASX: CAN) (OTC: CNGGF) announced an increase to its capital raise, boosting it to $58.7, seling  by shares $2.50 in a deal underwritten by Canaccord...
- December 3rd, 2017 at 10:47 pm

Cannabis REIT IIPR Seeks to Raise up to $100MM

One year after its debut on the NYSE and fewer than two months after completing its $15mm sale of preferred shares, Innovative Industrial Properties (NYSE: IIPR) has filed a...
- December 1st, 2017 at 6:02 pm

Maricann Prepares for Pharmacy Distribution and Exports to Europe

Maricann Group Inc. Files Third Quarter Financial Results, Updates Ongoing German License Progress and Distribution Efforts TORONTO, ONTARIO–(Marketwired – Dec. 1, 2017) – Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) (“Maricann” or...
- December 1st, 2017 at 6:16 am

Aurora Cannabis Remains Committed to CanniMed Takeover

Aurora Cannabis Responds to CanniMed’s Adoption of Poison Pill Tactic Reaffirms Commitment to Offer and Invitation to Tender Poison Pill Strips CanniMed Shareholders of Rights and Restricts Choices Not...
- November 30th, 2017 at 8:45 pm

MPX Bioceutical to Raise up to C$25 Million in Private Placement

MPX Bioceutical Corporation Announces $25 Million Private Placement of Units TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) (the “Company” or “MPX”) announced today that...
- November 30th, 2017 at 5:31 pm